Stable NaV Cell Lines for High-Throughput Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The discovery of new and improved therapeutics targeting voltage-gated sodium ion channels has been hampered by the lack of effective cell-based systems, particularly those suitable for high-throughput formats, which are necessary for identifying and testing NaV modulators, as existing systems either provide only binding assays or lack cytotoxicity testing.
Innovation Solution
Development of new cell lines that stably express heterologous NaV alpha and beta subunits, specifically human NaV 1.7 subunits, allowing for the formation of functional NaV proteins, enabling the use of cell-based systems for drug discovery and validation without the need for antibiotics or selective pressure, and providing a method for identifying modulators through membrane potential assays or electrophysiology.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cell-based systems are used for drug discovery, then functional assay capability and cytotoxicity testing are improved, but the lack of stable cell lines expressing functional NaV channels limits productivity and reliability
Solution Approach 1:
The patent applies preliminary action by pre-engineering stable cell lines that already express functional NaV channels with appropriate subunit combinations before drug screening begins. This preliminary preparation of functional expression systems eliminates the need for transient transfection during high-throughput screening, thereby enabling both reliable functional assays and high productivity simultaneously.
2Adaptability or versatility
If existing cell-based systems are used, then some binding assays are available, but the inability to simultaneously test cytotoxicity and provide functional assays reduces versatility
Solution Approach 1:
The patent applies universality by creating a single cell line platform that can perform multiple functions: functional NaV channel assays, cytotoxicity testing, and binding assays. The cell lines are designed with stable expression of NaV channel subunits combined with selectable markers and reporter systems, allowing one system to replace multiple specialized systems and thereby improve both versatility and productivity.
3Reliability
If stable expression of multiple NaV subunits is achieved, then functional NaV protein formation is improved, but the complexity of coordinating expression of alpha and beta subunits increases device complexity
Solution Approach 1:
The patent applies merging by combining multiple subunit expression cassettes into single integrated vectors or vector sets that co-express alpha and beta subunits from the same promoter or coordinated promoters. This merging of expression elements into unified constructs simplifies the transfection process and ensures stoichiometric expression of all subunits needed for functional NaV channel assembly, thereby achieving reliable functional expression without proportionally increasing complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the creation of stable cell lines that express functional NaV subunits, facilitating the identification and testing of NaV modulators, thereby overcoming the limitations of existing systems and providing a robust platform for drug discovery and validation.
Implementation Method 1
The alpha subunit forms the ion pore and is thought to be responsible for selective sodium conduction and voltage-dependent activation and inactivation
Implementation Method 2
The alpha subunit forms the ion pore and is thought to be responsible for selective sodium conduction
Implementation Method 3
Beta subunits have been shown to modify expression levels and biophysical characteristics of some alpha subunits
Data Source
AI summary
Cells and cell lines that express voltage-gated sodium ion channels (NaV) and methods for using the cells and cell lines are disclosed herein. The NaV-expressing cells and cell lines are useful in high throughput screening assays.